Log In
Sign Up
Erythropoietin, Recombinant Human
Indications
Symptomatic anaemia associated with CRF in adults and paediatrics; prevention of anaemia of prematurity in infants with a birth weight of 0.75-1.5kg and a gestational age < 34 wks; symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy; increasing the yield of autologous blood from patients in a pre-donation programme.
Dose/Application
Dose:SC: Initial dose: 3 x 20 IU/kg/wk increased every 4 wks by 3 x 20 IU/kg/ wk if the increase of Hb is < 0.25 g/dl/wk. IV: The initial dose: 3 x 40 IU/kg/wk increased after 4 wks to 80 IU/kg x 3 wkly up to 20 IU/kg x 3 per week, at monthly intervals [maximum dose < 720 IU/kg/wk. Main-tainance dose titrated to produce Hb of 10-12 g/dl
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Repoitin Inj 2000iu 1 KES900.00
Repoitin Inj 4000iu 1 KES1500.00
Relipoietin 2K, inj 2000iu 1 KES850.00
Relipoietin 4K, inj 4000iu 1 KES1550.00
Epotin. inj 2000iu 10 KES13,600.00
Epotin. inj 4000iu 10 KES19,200.00
Wepox. inj 2000iu 1 KES938.00
Wepox. inj 4000iu 1 KES2000.00
Eprex. inj 2000iu 6 KES7,385.00
Eprex. inj 4000iu 6 KES13,934.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us